Early vascular parameters in the micro- and macrocirculation in type 2 diabetes

Dennis Kannenkeril, Agnes Bosch, Joanna Harazny, Marina Karg, Susanne Jung, Christian Ott, Roland E Schmieder, Dennis Kannenkeril, Agnes Bosch, Joanna Harazny, Marina Karg, Susanne Jung, Christian Ott, Roland E Schmieder

Abstract

Background: Diabetes converts from a metabolic disorder into a predominantly vascular disease, once its duration extends over several years or/and when additional cardiovascular risk factors such as hypertension coexist. In a cross-sectional analysis we analyzed various vascular parameters in the renal, retinal and systemic circulation, with the goal to identify which vascular parameter of early organ damage is the earliest that can be clinically detected.

Methods: In 111 patients with type 2 diabetes (T2DM) (off any anti-diabetic medication for at least 4 weeks) and 54 subjects without T2DM we compared various parameters of early vascular remodeling in the same patient: urinary albumin creatinine ratio ([UACR], early morning spot urine) and estimated glomerular filtration rate (eGFR), retinal capillary flow (RCF) and intercapillary distance (ICD) as parameters of capillary rarefaction, wall-to-lumen ratio (WLR) of the retinal arterioles [all assessed by Scanning Laser Doppler Flowmetry], and central systolic pressure (cSBP) and central pulse pressure (cPP) [measured by pulse wave analysis, Syphygmocor] both reflecting vascular stiffness of large arteries.

Results: Compared to subjects without T2DM, patients with T2DM (diabetes duration: median 48 months, interquartile range 24-88 months) were older (59.8 ± 7.3 vs 43.4 ± 12.9 years, p < 0.001), more females (33.3 vs 20.4%, p < 0.001), but 24-h systolic and diastolic blood pressure did not differ between the two groups. The analysis adjusted for age, gender and cardiovascular risk factors revealed that ICD (23.9 ± 5.1 vs 20.8 ± 3.5 µm, p value = 0.001) and cPP (41.8 ± 11.7 vs 34.8 ± 10.6 mmHg, p value < 0.001) were significantly higher and eGFR (91.7 ± 9.9 vs 95.9 ± 17.3 ml/min/1.73 m2, p value < 0.001) was significantly lower in patients with T2DM than in subjects without T2DM.

Conclusion: These data suggest that at similar blood pressure capillary rarefaction in the retinal circulation (ICD), decreased eGFR in the renal circulation and increased central pulse pressure (cPP) of large arteries are earlier detectable than other vascular remodeling parameters of the micro- (WLR, RCF, UACR) and macrocirculation (cSBP) in patients with T2DM. Trial registration Trial registration number: NCT02471963, Date of registration: June 15, 2015, retrospectively registered; Trial registration number: NCT01319357, Date of registration: March 21, 2011, retrospectively registered; Trial registration number: NCT02383238, Date of registration: March 9, 2015, retrospectively registered; Trial registration number: NCT00152698, Date of registration: September 9, 2005, prospectively registered; Trial registration number: NCT00136188, Date of registration: August 26, 2005, prospectively registered.

Keywords: Central pulse pressure; Diabetes mellitus type 2; Inter capillary distance; Micro-and macrocirculation.

Figures

Fig. 1
Fig. 1
ICD in non-T2DM- and T2DM-subjects
Fig. 2
Fig. 2
eGFR in non-T2DM- and T2DM-subjects
Fig. 3
Fig. 3
cPP in non-T2DM- and T2DM-subjects

References

    1. Taguchi TBM. The biochemical mechanisms of diabetic tissue damage. 3. Oxford: Blackwell; 2003.
    1. Leiter LA. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabetes Res Clin Pract. 2005;68(Suppl 2):S3–S14. doi: 10.1016/j.diabres.2005.03.015.
    1. A Comprehensive report issued by the American Association of Clinical Endocrinologists.
    1. Rosenson RS, Fioretto P, Dodson PM. Does microvascular disease predict macrovascular events in type 2 diabetes? Atherosclerosis. 2011;218(1):13–18. doi: 10.1016/j.atherosclerosis.2011.06.029.
    1. Kawasaki R, Tanaka S, Tanaka S, Abe S, Sone H, Yokote K, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, et al. Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. Ophthalmology. 2013;120(3):574–582. doi: 10.1016/j.ophtha.2012.08.029.
    1. Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, Muggeo M, Arcaro G. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabetic Med. 2008;25(1):45–50. doi: 10.1111/j.1464-5491.2007.02327.x.
    1. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30(7):1742–1746. doi: 10.2337/dc07-0264.
    1. Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care. 2011;34(5):1238–1244. doi: 10.2337/dc11-0079.
    1. Yang X, Ma RC, So WY, Ko GT, Kong AP, Lam CW, Ho CS, Cockram CS, Wong VC, Tong PC, et al. Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients—the Hong Kong diabetes registry. Cardiovasc Diabetol. 2007;6:37. doi: 10.1186/1475-2840-6-37.
    1. Bruno G, Merletti F, Bargero G, Novelli G, Melis D, Soddu A, Perotto M, Pagano G, Cavallo-Perin P. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia. 2007;50(5):941–948. doi: 10.1007/s00125-007-0616-1.
    1. Gimeno-Orna JA, Lou-Arnal LM, Boned-Juliani B, Molinero-Herguedas E. Mild renal insufficiency as a cardiovascular risk factor in non-proteinuric type II diabetes. Diabetes Res Clin Pract. 2004;64(3):191–199. doi: 10.1016/j.diabres.2003.10.018.
    1. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20(8):1813–1821. doi: 10.1681/ASN.2008121270.
    1. Amin AP, Whaley-Connell AT, Li S, Chen SC, McCullough PA, Kosiborod MN. The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP) Am J Kidney Dis. 2013;61(4 Suppl 2):S12–S23. doi: 10.1053/j.ajkd.2013.01.005.
    1. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (London, England) 1982;1(8287):1430–1432. doi: 10.1016/S0140-6736(82)92450-3.
    1. Bilous R. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? Diabetic Med. 2008;25(Suppl 2):25–29. doi: 10.1111/j.1464-5491.2008.02496.x.
    1. Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, Weber MA, McQueen M, Koon T, Yusuf S. Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol. 2011;22(7):1353–1364. doi: 10.1681/ASN.2010091001.
    1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens. 2013;31(7):1281–1357. doi: 10.1097/.
    1. Adji A, O’Rourke MF. Determination of central aortic systolic and pulse pressure from the radial artery pressure waveform. Blood Press Monit. 2004;9(3):115–121. doi: 10.1097/01.mbp.0000132426.32886.e0.
    1. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension (Dallas, Tex: 1979) 2001;38(4):932–937. doi: 10.1161/hy1001.096106.
    1. Harazny JM, Raff U, Welzenbach J, Ott C, Ritt M, Lehmann M, Michelson G, Schmieder RE. New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens. 2011;29(4):777–782. doi: 10.1097/HJH.0b013e328343c27a.
    1. Michelson G, Welzenbach J, Pal I, Harazny J. Automatic full field analysis of perfusion images gained by scanning laser Doppler flowmetry. Br J Ophthalmol. 1998;82(11):1294–1300. doi: 10.1136/bjo.82.11.1294.
    1. Harazny JM, Ritt M, Baleanu D, Ott C, Heckmann J, Schlaich MP, Michelson G, Schmieder RE. Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension (Dallas, Tex: 1979) 2007;50(4):623–629. doi: 10.1161/HYPERTENSIONAHA.107.090779.
    1. Jumar A, Harazny JM, Ott C, Kistner I, Friedrich S, Schmieder RE. Improvement in retinal capillary rarefaction after valsartan treatment in hypertensive patients. J Clin Hypertens (Greenwich, Conn) 2016;18(11):1112–1118. doi: 10.1111/jch.12851.
    1. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
    1. Madero M, Sarnak MJ. Creatinine-based formulae for estimating glomerular filtration rate: is it time to change to chronic kidney disease epidemiology collaboration equation? Curr Opin Nephrol Hypertens. 2011;20(6):622–630. doi: 10.1097/MNH.0b013e32834ba210.
    1. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006;17(8):2100–2105. doi: 10.1681/ASN.2006050517.
    1. Mohammedi K, Woodward M, Marre M, Colagiuri S, Cooper M, Harrap S, Mancia G, Poulter N, Williams B, Zoungas S, et al. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):95. doi: 10.1186/s12933-017-0574-y.
    1. Krentz AJ, Clough G, Byrne CD. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab. 2007;9(6):781–791. doi: 10.1111/j.1463-1326.2007.00670.x.
    1. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension (Dallas, Tex: 1979) 1997;30(6):1410–1415. doi: 10.1161/01.HYP.30.6.1410.
    1. Doupis J, Papanas N, Cohen A, McFarlan L, Horton E. Pulse wave analysis by applanation tonometry for the measurement of arterial stiffness. Open Cardiovasc Med J. 2016;10:188–195. doi: 10.2174/1874192401610010188.
    1. Nilsson PM, Nilsson E, Gottsater M, Ostling G. 4D.12: aortic stiffness is modestly but equally associated with both central and brachial pulse pressure in elderly subjects. The Malmo diet cancer study. J Hypertens. 2015;33(Suppl 1):e63. doi: 10.1097/.
    1. Avolio A. Arterial stiffness. Pulse (Basel, Switzerland) 2013;1(1):14–28.
    1. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19(3):257–267. doi: 10.2337/diacare.19.3.257.
    1. Incalza MA, D’Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vasc Pharmacol. 2018;100:1–19. doi: 10.1016/j.vph.2017.05.005.
    1. Ohara M, Fukui T, Ouchi M, Watanabe K, Suzuki T, Yamamoto S, Yamamoto T, Hayashi T, Oba K, Hirano T. Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes. Diabetes Res Clin Pract. 2016;122:62–70. doi: 10.1016/j.diabres.2016.09.025.
    1. Credeur DP, Reynolds LJ, Holwerda SW, Vranish JR, Young BE, Wang J, Thyfault JP, Fadel PJ. Influence of physical inactivity on arterial compliance during a glucose challenge. Exp Physiol. 2018;108:483–494. doi: 10.1113/EP086713.
    1. Gordin D, Saraheimo M, Tuomikangas J, Soro-Paavonen A, Forsblom C, Paavonen K, Steckel-Hamann B, Vandenhende F, Nicolaou L, Pavo I, et al. Influence of postprandial hyperglycemic conditions on arterial stiffness in patients with type 2 diabetes. J Clin Endocrinol Metab. 2016;101(3):1134–1143. doi: 10.1210/jc.2015-3635.
    1. Striepe K, Jumar A, Ott C, Karg MV, Schneider MP, Kannenkeril D, Schmieder RE. Effects of the selective sodium–glucose cotransporter 2 inhibitor empagliflozin on vascular function and central hemodynamics in patients with type 2 diabetes mellitus. Circulation. 2017;136(12):1167–1169. doi: 10.1161/CIRCULATIONAHA.117.029529.
    1. Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117–2128. doi: 10.1056/NEJMoa1504720.
    1. Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE. Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. Diabetes Obes Metab. 2015;17(12):1180–1193. doi: 10.1111/dom.12572.
    1. Chen Q, Ma Q, Wu C, Tan F, Chen F, Wu Q, Zhou R, Zhuang X, Lu F, Qu J, et al. Macular vascular fractal dimension in the deep capillary layer as an early indicator of microvascular loss for retinopathy in type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2017;58(9):3785–3794. doi: 10.1167/iovs.17-21461.
    1. Cheung N, Donaghue KC, Liew G, Rogers SL, Wang JJ, Lim SW, Jenkins AJ, Hsu W, Li Lee M, Wong TY. Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care. 2009;32(1):106–110. doi: 10.2337/dc08-1233.
    1. Simonett JM, Scarinci F, Picconi F, Giorno P, De Geronimo D, Di Renzo A, Varano M, Frontoni S, Parravano M. Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus. Acta Ophthalmol. 2017;95(8):e751–e755. doi: 10.1111/aos.13404.
    1. Barchetta I, Riccieri V, Vasile M, Stefanantoni K, Comberiati P, Taverniti L, Cavallo MG. High prevalence of capillary abnormalities in patients with diabetes and association with retinopathy. Diabetic Med. 2011;28(9):1039–1044. doi: 10.1111/j.1464-5491.2011.03325.x.
    1. Jumar A, Ott C, Kistner I, Friedrich S, Schmidt S, Harazny JM, Schmieder RE. Effect of aliskiren on vascular remodelling in small retinal circulation. J Hypertens. 2015;33(12):2491–2499. doi: 10.1097/HJH.0000000000000735.
    1. Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun M, Li Q, MacMahon S, Cooper ME, Hamet P, Marre M, et al. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int. 2013;83(3):517–523. doi: 10.1038/ki.2012.401.
    1. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–2572. doi: 10.1056/NEJMoa0802987.
    1. Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, et al. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5(12):951–964. doi: 10.1016/S2213-8587(17)30327-3.
    1. Garhofer G, Bek T, Boehm AG, Gherghel D, Grunwald J, Jeppesen P, Kergoat H, Kotliar K, Lanzl I, Lovasik JV, et al. Use of the retinal vessel analyzer in ocular blood flow research. Acta Ophthalmol. 2010;88(7):717–722. doi: 10.1111/j.1755-3768.2009.01587.x.
    1. Wimpissinger B, Resch H, Berisha F, Weigert G, Schmetterer L, Polak K. Response of retinal blood flow to systemic hyperoxia in smokers and nonsmokers. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2005;243(7):646–652. doi: 10.1007/s00417-004-1083-8.
    1. Harazny JM, Schmieder RE, Welzenbach J, Michelson G. Local application of tropicamide 0.5% reduces retinal capillary blood flow. Blood Press. 2013;22(6):371–376. doi: 10.3109/08037051.2013.782956.
    1. Weber T, Wassertheurer S, Rammer M, Maurer E, Hametner B, Mayer CC, Kropf J, Eber B. Validation of a brachial cuff-based method for estimating central systolic blood pressure. Hypertension (Dallas, Tex: 1979) 2011;58(5):825–832. doi: 10.1161/HYPERTENSIONAHA.111.176313.
    1. Protogerou AD, Argyris A, Nasothimiou E, Vrachatis D, Papaioannou TG, Tzamouranis D, Blacher J, Safar ME, Sfikakis P, Stergiou GS. Feasibility and reproducibility of noninvasive 24-h ambulatory aortic blood pressure monitoring with a brachial cuff-based oscillometric device. Am J Hypertens. 2012;25(8):876–882. doi: 10.1038/ajh.2012.63.
    1. Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibirica E. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens. 2006;19(5):477–483. doi: 10.1016/j.amjhyper.2005.10.021.
    1. Lamb EJ, Stevens PE. Estimating and measuring glomerular filtration rate: methods of measurement and markers for estimation. Curr Opin Nephrol Hypertens. 2014;23(3):258–266. doi: 10.1097/01.mnh.0000444813.72626.88.
    1. Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis. 2014;63(5):820–834. doi: 10.1053/j.ajkd.2013.12.006.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit